Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Watterson

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Molecular Psychiatry|November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
Vaccines|July 27, 2024
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of BoosterTatiana A do Nascimento, Patricia Y Nogami, Camille F de Oliveira, et al.
Nature Communications|June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
Vaccines|May 28, 2022
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months DurationCamille F de Oliveira, Walter F F Neto, Carla P da Silva, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
The Lancet. Infectious Diseases|April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Molecular Psychiatry|November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
Vaccines|July 27, 2024
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of BoosterTatiana A do Nascimento, Patricia Y Nogami, Camille F de Oliveira, et al.
Nature Communications|June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
Vaccines|May 28, 2022
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months DurationCamille F de Oliveira, Walter F F Neto, Carla P da Silva, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Nature Communications|April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderlyKevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Pageof 12